HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cooper Divests Stardea To France's EA Pharma

Executive Summary

Italian nutraceutical player Stardea has changed hands. Following six years of ownership by Cooper Consumer Health, the business has been acquired by France's EA Pharma which is keen to expand its footprint outside of its home market.

You may also be interested in...

EU Business Round-Up: EA Pharma Acquires Drasanvi, Bios Line Attracts Investment, Diapharm Sets Up Swiss Office

The latest European consumer health business news: France's EA Pharma snaps up Spain's Drasanvi; Italy's Bios Line attracts minority investment; and Diapharm sets up in Switzerland to help device manufacturers.

Cooper Consumer Health Expands With France's Tradiphar

Cooper Consumer Health - formerly Alpha HealthGroup - said it had gained a portfolio of "high profile brands" and strengthened its position in Europe's OTC market with the acquisition of France's Tradiphar.

Nestlé Partner Valbiotis Hails Trial Results For Prediabetes Supplement

Valbiotis and Nestlé Health Science plan to launch in 2024 a dietary supplement targeted at sufferers of prediabetes and type-2 diabetes following positive results from a recent study which showed the product's efficacy on key markers of glucose metabolism.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts